Cathy Mihalopoulos

Informal Care for Stroke Survivors: Results From the North East Melbourne Stroke Incidence Study (NEMESIS)

Background and Purpose— Informal caregivers play an important role in the lives of stroke patients, but the cost of providing this care has not been estimated. The purpose of this study was to determine the nature and amount of informal care provided to stroke patients and to estimate the economic cost of that care. Methods— The primary caregivers of stroke patients registered in the North East Melbourne Stroke Incidence Study (NEMESIS) were interviewed at 3, 6, and 12 months after stroke, and the nature and amount of informal care provided were documented. The opportunity and replacement costs of informal care for all first-ever-in-a-lifetime strokes (excluding subarachnoid hemorrhages) that occurred in 1997 in Australia were estimated. Results— Among 3-month stroke survivors, 74% required assistance with activities of daily living and received informal care from family or friends. Two thirds of primary caregivers were women, and most primary caregivers (>90%) provided care during family or leisure time. Total first-year caregiver time costs for all first-ever-in-a-lifetime strokes were estimated to be A

Lifetime Cost of Stroke Subtypes in Australia Findings From the North East Melbourne Stroke Incidence Study (NEMESIS)

21.7 million (opportunity cost approach) or A

The Economic Analysis of Prevention in Mental Health Programs

42.5 million (replacement cost approach), and the present values of lifetime caregiver time costs were estimated to be A

The cost—effectiveness of call-back counselling for smoking cessation

171.4 million (opportunity cost approach) or A

Modelled cost-effectiveness evaluation of bipolar disorder treatments to guide health policy

331.8 million (replacement cost approach). Conclusions— Informal care for stroke survivors represents a significant hidden cost to Australian society. Because our community is rapidly aging, this informal care burden may increase significantly in the future.

Cost of stroke in Australia from a societal perspective. Results from the North East Melbourne Stroke Incidence Study (NEMESIS)

Background and Purpose— Little is known about any variations in resource use and costs of care between stroke subtypes, especially nonhospital costs. The purpose of this study was to describe the patterns of resource use and to estimate the first-year and lifetime costs for stroke subtypes. Methods— A cost-of-illness model was used to estimate the total first-year costs and lifetime costs of stroke subtypes for all strokes (subarachnoid hemorrhages excluded) that occurred in Australia during 1997. For each subtype, average cost per case during the first year and the present value of average cost per case over a lifetime were calculated. Resource use data obtained in the North East Melbourne Stroke Incidence Study (NEMESIS) were used. Results— The present value of total lifetime costs for all strokes was Aus

Trial of Program Budgetting and Marginal Analysis (PBMA) to assist cancer control planning in Australia

1.3 billion (US

'Out of pocket' costs to stroke patients during the first year after stroke - results from the North East Melbourne Stroke Incidence Study.

985 million). Total lifetime costs were greatest for ischemic stroke (72%; Aus

Data used in the Development of the AQoL-8D (PsyQoL) Quality of Life Instrument

936.8 million; US

The AQoL-8D (PsyQoL) MAU Instrument: Overview September 2009

709.7 million), followed by intracerebral hemorrhage (26%; Aus